Recruiting

CTAC & Navigation

Sponsor:

Fred Hutchinson Cancer Center

Code:

NCT06995924

Conditions

Stage I Colorectal Cancer AJCC v8

Stage II Colorectal Cancer AJCC v8

Stage III Colorectal Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Educational Intervention

Electronic Health Record Review

Internet-Based Intervention

Patient Navigation

Survey Administration

Study Details

Brief summary:

This pilot clinical trial looks at whether patient navigation services, an interactive web education intervention, called Current Together After Cancer (CTAC), or both navigation and CTAC works to improve the uptake of surveillance in patients with stage I-III colorectal cancer (CRC). Post-treatment surveillance is critical to detect recurrence early, yet many CRC survivors do not receive recommended surveillance care. Surveillance is a complex process that includes laboratory tests, cross-sectional imaging, and endoscopic procedures. Patient navigation services, interactive web education, or a combination of both may improve surveillance care for patients with stage I-III colorectal cancer.

Conditions

Stage I Colorectal Cancer AJCC v8

Stage II Colorectal Cancer AJCC v8

Stage III Colorectal Cancer AJCC v8

Study ID

NCT06995924

Start date

Nov 17, 2025

Status verified date

Aug, 2026

Completion date

Mar 31, 2027

Anticipated

Primary completion date

Mar 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age ≥ 18 due to disease and clinic population
  • Stage I-III CRC survivor within 3 months post-surgical resection
  • Being seen at a participating clinic
  • Ability to understand and complete surveys in English

Study Design

Enrollment

75 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Arm A (navigation)

Patients receive access to navigation services, in person, via telephone or via electronic conferencing platform, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, within 3 months of standard of care surgical resection.

experimental: Arm B (CTAC)

Patients receive access to the online CTAC intervention, which includes self-directed, interactive education about surveillance and a checklist of care, within 3 months of standard of care surgical resection.

experimental: Arm C (navigation and CTAC)

Patients receive access to navigation services, in person, via telephone or via electronic conferencing platform, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, and access to the online CTAC intervention, which includes self-directed, interactive education about surveillance and a checklist of care, within 3 months of standard of care surgical resection.

Interventions

Educational Intervention

Complete self-directed interactive education

Electronic Health Record Review

Ancillary studies

Internet-Based Intervention

Receive access to CTAC

Patient Navigation

Receive patient navigation services

Survey Administration

Ancillary studies

Primary outcome measure

  • Completion of colonoscopy (stage I colorectal carcinoma patients) [ Time Frame: Up to 18 months post-surgical resection ]
  • Completing any colonoscopy, carcinoembryonic antigen tumor marker (CEA), and cross-sectional imaging (stage II-III colorectal carcinoma patients) [ Time Frame: Up to 18 months post-surgical resection ]

Central Contacts and Locations

Central contacts

Ari Bell-Brown

206.667.7624abellbro@fredhutch.org

Locations

Benaroya Research Institute at Virginia Mason

Recruiting

Seattle, Washington, United States, 98101

Principal Investigator:

Vlad Simianu, MD, MPH, FACS, FASCRS

Fred Hutch/University of Washington Cancer Consortium

Recruiting

Seattle, Washington, United States, 98109

Contacts

Ari Bell-Brown

206-667-7624abellbro@fredhutch.org

Principal Investigator:

Rachel B. Issaka, MD, MAS

More Information

Sponsor

Fred Hutchinson Cancer Center

Last update posted

Sep 1, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Fred Hutchinson Cancer Center on 2026-09-01.